SLIWENS Trademark

Trademark Overview

On Friday, April 21, 2006, a trademark application was filed for SLIWENS with the United States Patent and Trademark Office. The USPTO has given the SLIWENS trademark a serial number of 79025521. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, April 22, 2016. This trademark is owned by SANOFI-AVENTIS. The SLIWENS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, with the exception of analgesics, for the treatment of central nervous system diseases
sliwens

General Information

Serial Number79025521
Word MarkSLIWENS
Filing DateFriday, April 21, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, April 22, 2016
Registration Number3253979
Registration DateTuesday, June 19, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations, with the exception of analgesics, for the treatment of central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 24, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameSANOFI-AVENTIS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameSANOFI-AVENTIS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, November 4, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, November 4, 2016DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 6, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, April 8, 2015GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, April 8, 2015GENERIC MADRID TRANSACTION CREATED
Wednesday, September 24, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 24, 2014CANCELLED SECTION 71
Saturday, July 21, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, December 11, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 7, 2007FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 7, 2007FINAL DISPOSITION PROCESSED
Tuesday, November 6, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 19, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, April 3, 2007PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2007NOTICE OF PUBLICATION
Monday, February 12, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 12, 2007ASSIGNED TO LIE
Wednesday, January 31, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 30, 2007AMENDMENT FROM APPLICANT ENTERED
Tuesday, January 30, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 30, 2007ASSIGNED TO LIE
Wednesday, January 3, 2007PAPER RECEIVED
Friday, October 13, 2006REFUSAL PROCESSED BY IB
Wednesday, October 11, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 27, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 27, 2006REFUSAL PROCESSED BY MPU
Tuesday, September 26, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 25, 2006NON-FINAL ACTION WRITTEN
Thursday, September 21, 2006ASSIGNED TO EXAMINER
Friday, August 11, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, August 10, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

sliwens nervous system diseases central treatment preparations exception analgesics pharmaceutical